Compare Merck & Co., Inc. (MRK) vs Peloton Interactive Inc (PTON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs Peloton Interactive Inc — how do they compare? Merck & Co., Inc. trades at $145.6 (market cap $351.28B), while Peloton Interactive Inc trades at $5.12 (market cap $2.16B). The key difference: Merck & Co., Inc. is far larger — about 162.6× Peloton Interactive Inc's market cap, and Merck & Co., Inc. pays a 2.39% dividend while Peloton Interactive Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Merck & Co., Inc. for 98 Days and Peloton Interactive Inc for 37 Days on average.
| MRK | PTON | |
|---|---|---|
Market Cap | $351.28B | $2.16B |
Volume | 7,969,665 | 11,369,487 |
Sector | Health | Consumer Cyclical |
52-Week High | $156.43 | $7.86 |
52-Week Low | $82.49 | $3.71 |
Typical Hold Time | 98 Days | 37 Days |
Enterprise Value | $398.04B | $2.66B |
Dividend Yield | 2.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Merck (MRK) trades at $142.40, down 0.28% on the day, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending. Revenue grew to $65.01 billion in 2025, and net income reached $18.25 billion. Recent news highlights Merck's acquisition of Terns Pharmaceuticals to bolster its oncology pipeline, with institutional investors increasing stakes.
The outlook for Merck is supported by analyst consensus with a $158.78 price target and 68% buy ratings, but risks include high valuation multiples like a P/E of 113.9 and competitive pressures in the pharma sector. The stock's investment appeal hinges on pipeline execution and integration of acquisitions amid a challenging technical backdrop.
Peloton (PTON) trades at $4.92, up 1.44% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported its first full-year net profit in fiscal 2026, with revenue of $2.49B in 2025 and improving margins. Recent news highlights the launch of new, more affordable treadmills and AI-powered features as part of its turnaround strategy.
The outlook is mixed; analyst consensus is a Buy with a $8.00 price target, signaling potential upside, but risks include high debt, negative equity, and subscriber declines. Execution of the product refresh and cost management will be critical for sustained profitability and stock performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About Peloton Interactive Inc
Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.
Read more on PTON →
